Immunotherapy Response Predicted by Liquid Biopsy – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Immunotherapy Response Predicted by Liquid Biopsy
Genetic Engineering & Biotechnology News "We can help predict response to immunotherapy by measuring the number of mutations in circulating tumor DNA [ctDNA] using a simple blood test," said Yulian Khagi, M.D., University of California San Diego Moores Cancer Center fellow and first author. DNA mutations in blood predict response to immunotherapy DNA mutations shed in blood predicts response to immunotherapy in patients with cancer Study Demonstrates Potential for the Guardant360 Assay® to Predict Which Patients Will Benefit from Immunotherapy |
